Pallas Capital Advisors’s Organogenesis Holdings ORGO Stock Holding History

Pallas Capital Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$44.3K	Sell	18,685 -1,028	-5%	-$3.56K	﹤0.01%	836
2025 Q4	$102K	Buy	19,713 +6	+0%	+$29	﹤0.01%	843
2025 Q3	$83.2K	Buy	19,707 +6	+0%	+$28	﹤0.01%	834
2025 Q2	$72.1K	Sell	19,701 -3,755	-16%	-$14K	﹤0.01%	811
2025 Q1	$101K	Buy	23,456 +1,863	+9%	+$7.52K	﹤0.01%	708
2024 Q4	$69.1K	Sell	21,593 -230	-1%	-$772	﹤0.01%	570
2024 Q3	$62.6K	Buy	21,823 +9,048	+71%	+$25.4K	﹤0.01%	587
2024 Q2	$37.6K	Buy	+12,775	New	+$34.3K	﹤0.01%	498

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Pallas Capital Advisors's ORGO Position: Q1 2026 in Review

Pallas Capital Advisors reduced its Organogenesis Holdings (ORGO) stake by 5.2% in Q1 2026, selling an estimated $3.56K and leaving 18,685 shares worth $44.3K. The position accounts for ﹤0.01% of the portfolio, ranked #836.

Pallas Capital Advisors first reported a position in ORGO in Q2 2024 and has held it in 8 quarters since. The position peaked at $102K in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

Pallas Capital Advisors held 18,685 shares of Organogenesis Holdings worth $44.3K as of Q1 2026.
Pallas Capital Advisors sold 1,028 Organogenesis Holdings shares in Q1 2026, an estimated $3.56K.
Organogenesis Holdings made up ﹤0.01% of Pallas Capital Advisors's portfolio in Q1 2026, its #836 holding.
Pallas Capital Advisors first reported a position in Organogenesis Holdings in Q2 2024 and has held it in 8 quarters since.
Pallas Capital Advisors's Organogenesis Holdings position peaked at $102K in Q4 2025.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.